Humanwell Pharmaceutical US, Inc.
is a Missouri-based pharmaceutical research and development company that focuses on the development of novel therapies to address unmet medical needs. Aiming for more affordable and accessible medication, we are at the forefront of advancing pain medication. Our focus lies in creating pharmaceutical products that will make a distinctive difference for people in need. Our new drug design center in the company is also developing novel peptide and small molecules to treat symptoms such as pain, stress, anxiety, inflammation, and post-operative nausea and vomiting.
Humanwell US is a subsidiary company of Yichang Humanwell Pharmaceutical Co. LTD, a market leader in anesthetic and pain medications in China. With over 70 patents, original anesthetic APIs, and finished dosages, Yichang Humanwell exists as a leading global pharmaceutical company. More than 4,000 employees work together to deliver products to over 20 countries, helping to make the world a healthier place.